ANGPTL8 and hepatocellular carcinoma: To determine whether our findings in ANGPTL8-OE models could be attributed to ERK signaling, we treated HCC and primary liver cells overexpressing ANGPTL8 with the ERK inhibitor FR180204 and measured cell proliferation.